Searching News Database: Somaxon Pharmaceuticals
HSMN NewsFeed - 18 Mar 2016
ProNAi Therapeutics Appoints Jeffrey H. Cooper and Tran Nguyen to its Board of Directors
ProNAi Therapeutics Appoints Jeffrey H. Cooper and Tran Nguyen to its Board of Directors
HSMN NewsFeed - 4 Jun 2014
Cohera Medical, Inc.(R) Appoints Richard W. Pascoe to its Board of Directors
Cohera Medical, Inc.(R) Appoints Richard W. Pascoe to its Board of Directors
HSMN NewsFeed - 5 Feb 2013
Somaxon Pharmaceuticals Announces Settlement of Silenor Patent Litigation With Actavis
Somaxon Pharmaceuticals Announces Settlement of Silenor Patent Litigation With Actavis
HSMN NewsFeed - 11 Dec 2012
Pernix Therapeutics Announces Agreement to Acquire Somaxon Pharmaceuticals, Inc.
Pernix Therapeutics Announces Agreement to Acquire Somaxon Pharmaceuticals, Inc.
HSMN NewsFeed - 19 Jul 2012
Somaxon Pharmaceuticals Announces Settlement of Silenor Patent Litigation With Zydus
Somaxon Pharmaceuticals Announces Settlement of Silenor Patent Litigation With Zydus
HSMN NewsFeed - 25 Aug 2010
Somaxon Pharmaceuticals Announces Silenor(R) Co-Promotion Agreement with Procter & Gamble
Somaxon Pharmaceuticals Announces Silenor(R) Co-Promotion Agreement with Procter & Gamble
HSMN NewsFeed - 12 Apr 2010
Somaxon Pharmaceuticals Appoints Chief Financial Officer and Announces Senior Leadership Promotions
Somaxon Pharmaceuticals Appoints Chief Financial Officer and Announces Senior Leadership Promotions
HSMN NewsFeed - 30 Mar 2010
Cadence Pharmaceuticals Appoints Michael L. Eagle to its Board of Directors
Cadence Pharmaceuticals Appoints Michael L. Eagle to its Board of Directors
HSMN NewsFeed - 18 Mar 2010
Somaxon Announces FDA Approval of Silenor(R) (doxepin) for the Treatment of Insomnia
Somaxon Announces FDA Approval of Silenor(R) (doxepin) for the Treatment of Insomnia
HSMN NewsFeed - 18 Aug 2008
Somaxon Pharmaceuticals Announces the Appointment of Senior Commercial Leadership
Somaxon Pharmaceuticals Announces the Appointment of Senior Commercial Leadership
HSMN NewsFeed - 7 Aug 2008
Somaxon Pharmaceuticals Appoints Richard W. Pascoe as President and Chief Executive Officer
Somaxon Pharmaceuticals Appoints Richard W. Pascoe as President and Chief Executive Officer
HSMN NewsFeed - 31 Jan 2008
Somaxon Pharmaceuticals Submits New Drug Application for SILENOR(TM) for the Treatment of Insomnia
Somaxon Pharmaceuticals Submits New Drug Application for SILENOR(TM) for the Treatment of Insomnia
HSMN NewsFeed - 6 Dec 2007
Somaxon Pharmaceuticals Names David F. Hale Executive Chairman and Interim Chief Executive Officer
Somaxon Pharmaceuticals Names David F. Hale Executive Chairman and Interim Chief Executive Officer
HSMN NewsFeed - 9 May 2007
Somaxon Pharmaceuticals Provides Update on SILENOR(TM) Development Program
Somaxon Pharmaceuticals Provides Update on SILENOR(TM) Development Program
HSMN NewsFeed - 29 Jan 2007
Somaxon Pharmaceuticals Names Robert Jones Vice President, Human Resources
Somaxon Pharmaceuticals Names Robert Jones Vice President, Human Resources
HSMN NewsFeed - 13 Nov 2006
Somaxon Pharmaceuticals Names Brian Dorsey Vice President of Manufacturing and Program Management
Somaxon Pharmaceuticals Names Brian Dorsey Vice President of Manufacturing and Program Management
HSMN NewsFeed - 12 Oct 2006
Favrille Appoints Former Eli Lilly Executive Michael Eagle Chairman of the Board
Favrille Appoints Former Eli Lilly Executive Michael Eagle Chairman of the Board
HSMN NewsFeed - 19 Jul 2006
Somaxon Pharmaceuticals Provides Update on SILENOR(TM) Development Program for the Treatment of Insomnia
Somaxon Pharmaceuticals Provides Update on SILENOR(TM) Development Program for the Treatment of Insomnia
HSMN NewsFeed - 15 May 2006
Somaxon Pharmaceuticals Names Matthew Onaitis Vice President of Legal Affairs
Somaxon Pharmaceuticals Names Matthew Onaitis Vice President of Legal Affairs
Additional items found! 10
Members Archive contains
10 additional stories matching:
Somaxon Pharmaceuticals
(Password required)
Somaxon Pharmaceuticals
(Password required)